Annual Total Long Term Liabilities
$224.51 M
-$54.39 M-19.50%
31 December 2023
Summary:
bluebird bio annual total long term liabilities is currently $224.51 million, with the most recent change of -$54.39 million (-19.50%) on 31 December 2023. During the last 3 years, it has risen by +$1.90 million (+0.85%). BLUE annual total long term liabilities is now -19.50% below its all-time high of $278.90 million, reached on 31 December 2022.BLUE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$174.81 M
-$19.47 M-10.02%
30 September 2024
Summary:
bluebird bio quarterly total long term liabilities is currently $174.81 million, with the most recent change of -$19.47 million (-10.02%) on 30 September 2024. Over the past year, it has dropped by -$57.30 million (-24.69%). BLUE quarterly long term liabilities is now -37.32% below its all-time high of $278.90 million, reached on 31 December 2022.BLUE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLUE Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -19.5% | -24.7% |
3 y3 years | +0.8% | -13.7% |
5 y5 years | +6.2% | -22.1% |
BLUE Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -19.5% | +237.5% | -37.3% | +162.8% |
5 y | 5 years | -19.5% | +237.5% | -37.3% | +162.8% |
alltime | all time | -19.5% | +897.6% | -37.3% | +910.2% |
Bluebird Bio Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $174.81 M(-10.0%) |
June 2024 | - | $194.28 M(-6.1%) |
Mar 2024 | - | $206.86 M(-7.9%) |
Dec 2023 | $224.51 M(-19.5%) | $224.51 M(-3.3%) |
Sept 2023 | - | $232.12 M(-3.0%) |
June 2023 | - | $239.36 M(+7.8%) |
Mar 2023 | - | $222.06 M(-20.4%) |
Dec 2022 | $278.90 M(+319.2%) | $278.90 M(+18.9%) |
Sept 2022 | - | $234.51 M(-4.1%) |
June 2022 | - | $244.62 M(+188.1%) |
Mar 2022 | - | $84.92 M(+27.7%) |
Dec 2021 | $66.53 M(-70.1%) | $66.53 M(-67.2%) |
Sept 2021 | - | $202.56 M(-8.8%) |
June 2021 | - | $222.13 M(-3.7%) |
Mar 2021 | - | $230.63 M(+3.6%) |
Dec 2020 | $222.61 M(+1.7%) | $222.61 M(-1.3%) |
Sept 2020 | - | $225.56 M(-1.3%) |
June 2020 | - | $228.58 M(+1.9%) |
Mar 2020 | - | $224.25 M(+2.5%) |
Dec 2019 | $218.85 M(+3.6%) | $218.85 M(-2.5%) |
Sept 2019 | - | $224.48 M(-0.2%) |
June 2019 | - | $224.86 M(+2.3%) |
Mar 2019 | - | $219.82 M(+4.0%) |
Dec 2018 | $211.34 M | $211.34 M(-3.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | $219.36 M(+16.9%) |
June 2018 | - | $187.72 M(-0.6%) |
Mar 2018 | - | $188.85 M(+4.0%) |
Dec 2017 | $181.52 M(+4.2%) | $181.52 M(-3.3%) |
Sept 2017 | - | $187.64 M(+4.7%) |
June 2017 | - | $179.27 M(-2.9%) |
Mar 2017 | - | $184.56 M(+6.0%) |
Dec 2016 | $174.15 M(+56.2%) | $174.15 M(+11.5%) |
Sept 2016 | - | $156.16 M(+10.0%) |
June 2016 | - | $142.00 M(+6.6%) |
Mar 2016 | - | $133.23 M(+19.5%) |
Dec 2015 | $111.47 M(+395.3%) | $111.47 M(+17.3%) |
Sept 2015 | - | $95.06 M(+82.2%) |
June 2015 | - | $52.17 M(+201.5%) |
Mar 2015 | - | $17.30 M(-23.1%) |
Dec 2014 | $22.50 M(-40.5%) | $22.50 M(-24.4%) |
Sept 2014 | - | $29.78 M(-15.7%) |
June 2014 | - | $35.32 M(+9.4%) |
Mar 2014 | - | $32.30 M(-14.7%) |
Dec 2013 | $37.85 M(-68.6%) | $37.85 M(-3.1%) |
Sept 2013 | - | $39.07 M(-9.0%) |
June 2013 | - | $42.92 M(-12.9%) |
Mar 2013 | - | $49.26 M(-59.1%) |
Dec 2012 | $120.44 M(+43.8%) | $120.44 M |
Dec 2011 | $83.73 M | - |
FAQ
- What is bluebird bio annual total long term liabilities?
- What is the all time high annual total long term liabilities for bluebird bio?
- What is bluebird bio annual total long term liabilities year-on-year change?
- What is bluebird bio quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for bluebird bio?
- What is bluebird bio quarterly long term liabilities year-on-year change?
What is bluebird bio annual total long term liabilities?
The current annual total long term liabilities of BLUE is $224.51 M
What is the all time high annual total long term liabilities for bluebird bio?
bluebird bio all-time high annual total long term liabilities is $278.90 M
What is bluebird bio annual total long term liabilities year-on-year change?
Over the past year, BLUE annual total long term liabilities has changed by -$54.39 M (-19.50%)
What is bluebird bio quarterly total long term liabilities?
The current quarterly long term liabilities of BLUE is $174.81 M
What is the all time high quarterly long term liabilities for bluebird bio?
bluebird bio all-time high quarterly total long term liabilities is $278.90 M
What is bluebird bio quarterly long term liabilities year-on-year change?
Over the past year, BLUE quarterly total long term liabilities has changed by -$57.30 M (-24.69%)